Mokry, Lauren E.
Zhou, Sirui
Guo, Cong
Scott, Robert A.
Devey, Luke
Langenberg, Claudia
Wareham, Nick
Waterworth, Dawn
Cardon, Lon
Sanseau, Philippe
Davey Smith, George
Richards, J. Brent http://orcid.org/0000-0002-3746-9086
Funding for this research was provided by:
Canadian Institutes of Health Research
Article History
Received: 13 February 2018
Accepted: 30 May 2019
First Online: 28 June 2019
Competing Interests
: R.A.S., L.D., D.W., L.C. and P.S. were employed by GlaxoSmtihKline at the time of manuscript preparation and submission. L.D. was employed by Celgene at the time of manuscript resubmission. This did not influence findings or the interpretation of results. J.B.R.’s affiliated research institute has received funding from GlaxoSmithKline to explore drug repositioning opportunities. The remaining authors declare that no competing interests exist.